Current Drug Safety


Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne


Become EABM
Become Reviewer

NSAID Use and the Risk of Parkinsons Disease

Volume:1   Issue: 3
Pp: 223-225
Mahyar Etminan and Samy Suissa
DOI: 10.2174/157488606777934404

The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly

Volume:1   Issue: 3
Pp: 227-241
Subramoniam Madhusoodanan, Abhishek Sinha, Martha Sajatovic, Sanjay Gupta and Ronald Brenner
DOI: 10.2174/157488606777934468

Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy

Volume:1   Issue: 3
Pp: 253-257
Thomas Wirth, Marja Hedman, Kimmo Makinen, Hannu Manninen, Arto Immonen, Matti Vapalahti and Seppo Yla-Herttuala
DOI: 10.2174/157488606777934440

Oral Antiplatelet Agents and Bleeding Risk in Relation to Major Cardiovascular Surgery

Volume:1   Issue: 3
Pp: 281-287
James McCaslin, Jonathan Smout, Patrick Kesteven and Gerard Stansby
DOI: 10.2174/157488606777934486

Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions

Volume:1   Issue: 3
Pp: 289-299
Norberto Krivoy, Masud Taer and Manuela G. Neuman
DOI: 10.2174/157488606777934459

Drug-Induced Hair Disorders

Volume:1   Issue: 3
Pp: 301-305
Bianca Maria Piraccini, Matilde Iorizzo, Giulia Rech and Antonella Tosti
DOI: 10.2174/157488606777934477

Evaluating Drug Safety in Children and Adolescents with Bipolar Disorder

Volume:1   Issue: 3
Pp: 307-318
Pamela C. Heaton, Colleen M. Garlick and Doan Tran
DOI: 10.2174/157488606777934396